1h Free Analyst Time
The malabsorption syndrome market is forecasted to grow by USD 843 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the malabsorption syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of lactose intolerance, and government initiatives and awareness programs.
The malabsorption syndrome market is segmented as below:
- By Disease Type
- Lactose intolerance
- Sprue
- Cystic fibrosis
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the malabsorption syndrome market covers the following areas:
- Malabsorption syndrome market sizing
- Malabsorption syndrome market forecast
- Malabsorption syndrome market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global malabsorption syndrome market: AbbVie Inc., Aspen Pharmacare Holdings Ltd., Bausch Health Companies Inc., Baxter International Inc., Cosmo Pharmaceuticals NV, Ferring BV, Koninklijke DSM NV, Lannett Co. Inc., Merck and Co. Inc., Novartis AG, Organon and Co., Perrigo Co. Plc, Pfizer Inc., ProThera Biologics Inc., Sanofi SA, Tillotts Pharma AG, and Xspire Pharma LLC.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase prevalence of cystic fibrosis in europe, north america, and south america."
According to the report, one of the major drivers for this market is the higher consumption of gluten-containing food.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Aspen Pharmacare Holdings Ltd.
- Bausch Health Companies Inc.
- Baxter International Inc.
- Cosmo Pharmaceuticals NV
- Ferring BV
- Koninklijke DSM NV
- Lannett Co. Inc.
- Merck and Co. Inc.
- Novartis AG
- Organon and Co.
- Perrigo Co. Plc
- Pfizer Inc.
- ProThera Biologics Inc.
- Sanofi SA
- Tillotts Pharma AG
- Xspire Pharma LLC
